Using genetic screening, scientists have found a new drug combination that works against some treatment-resistant lung, brain and pancreatic cancers.

The FDA's top regulator of cancer drugs played a key role in the rejection of a skin cancer therapy from Replimune Group, ...

Experts highlight advances in therapies, research on skin of color, and the impact of social determinants of health at the ...

Patients with PWS who are treated with hemoporfin-mediated PDT have an increased prevalence of dermatitis and skin barrier damage.